ClinicalTrials.gg
Sign In

Eosinophilic Esophagitis clinical trials

The registry lists 235 studies for Eosinophilic Esophagitis across more than 10 countries. 53 are recruiting or about to start. 201 of them are mainly about Eosinophilic Esophagitis (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-13.

Get an email when these change. Save the Eosinophilic Esophagitis studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
121
Recruiting
42
Active, not recruiting
18
Terminated
17
Withdrawn
13
Status unknown
11

Phase

Phase 2
50
Phase 3
28
Phase 1
15
Phase 4
11
Early Phase 1
3

Where

United States
165
Italy
21
Germany
17
Canada
17
Switzerland
15
Spain
13

Who runs them

Mayo Clinic (24) · Children's Hospital Medical Center, Cincinnati (13) · University of North Carolina, Chapel Hill (9) · University of Colorado, Denver (8) · Regeneron Pharmaceuticals (7) · National Institute of Allergy and Infectious Diseases (NIAID) (7) · Ann & Robert H Lurie Children's Hospital of Chicago (6) · Allakos Inc. (6)

What is being tested here

Drugs under test in Eosinophilic Esophagitis studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Dupilumab4311
Budesonide1718
Fluticasone1411
Cord blood101
Upadacitinib101
Alpha 1-Antitrypsin101
AK002046
Cendakimab024
APT-1011034
Esomeprazole013

Drug classes tested here Corticosteroids 2 open · Proton pump inhibitors (PPIs) 7

Coming up

3phase 3 studies under way
17studies finish main data collection within a year1 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest, phase 3 first

Who these studies take

Of the 42 Eosinophilic Esophagitis studies recruiting now, 12 (29%) set no upper age limit and 27 (64%) stop at 75 or younger. 27 (64%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 7 (17%) take healthy volunteers.

Recruiting studies that take each age, of 42
AgeWomenMen
1024 (57%)24 (57%)
1834 (81%)34 (81%)
3025 (60%)25 (60%)
4025 (60%)25 (60%)
5025 (60%)25 (60%)
6524 (57%)24 (57%)
7517 (40%)17 (40%)
8515 (36%)15 (36%)

Across all 235 studies, recruiting or not: 58% stop at 75 or younger and 45% at 65; 52% take children; 0% are for women only and <1% for men only; 16% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Eosinophilic Esophagitis studies take

Of 24 phase 2 interventional studies under Eosinophilic Esophagitis, half reached primary completion within 24 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Phase 224 mo15–28 · 24 studies——
Phase 334 mo17–37 · 16 studies——
Interventional, no phase34 mo24–41 · 23 studies——
Observational49 mo22–120 · 55 studies—49 mo22–120 · 52 studies

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

Studies

Recruiting first, then most recently updated. Showing 50 of 235. Browse all 235 → or search them.